Amorepacific Corporation

Hyun Woo Jeong

Yong Deog Hong

Sang Jun Lee

Dae Bang Seo

Si Young Cho

Chan Woong Park

Wan Gi Kim

Su Kyung Kim

Byung Gyu Kim

Hyun Jung Shin

Ji Hae Lee

Dae Jin Min

Wanki Kim

Miyoung Park

Yong-Deog Hong

Jeong-kee Kim

Ayoung Kim

Su Hwan Kim

Sangyoul Na

Jisung Kim

The present disclosure relates to a composition for reducing body fat, which contains a green tea extract containing 4 wt % or more of gallocatechin gallate based on the total weight of the extract as an active ingredient, and a method for preparing the same. The composition according to the present disclosure provides a superior effect of reducing body fat as the green tea extract containing gallocatechin gallate is contained as an active ingredient. Accordingly, it can provide substances effective for treating obesity through various researches.

Composition for reducing body fat comprising green tea extract containing gallocatechin gallate as an active ingredient and manufacturing method thereof

The present specification relates to (20S,24R)-6-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel ginsenoside exhibits excellent anti-inflammatory effects.

Ginsenoside and anti-inflammatory composition comprising same

The present disclosure relates to an emulsion composition containingseed oil andberry extract, wherein the composition is a single phase. Whereas the existing composition containing a water-soluble ingredient as a main ingredient has the problem that, whenseed oil is added, formulation stability is decreased as theseed oil is separated from the water-soluble ingredient, the emulsion composition according to the present disclosure exhibits superior stability because theseed oil is uniformly mixed with the water-soluble ingredient and separation of theseed oil from the water-soluble ingredient does not occur fora long period of time.

Composition comprising ginseng seed oil

The present disclosure relates to a composition comprising (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for preventing or improving menopausal symptoms, which comprises administering an effective amount of (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside has a superior effect of preventing or improving menopausal symptoms with a low risk of breast cancer.

Composition for preventing or improving menopausal symptom comprising novel ginsenoside

The present disclosure relates to a composition comprising (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, which is a novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof as an active ingredient. In addition, it relates to a method for improving skin elasticity or skin wrinkles, which comprises administering an effective amount of (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof to a subject in need thereof. The novel ginsenoside, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof has a superior effect of improving skin elasticity and skin wrinkles.

Composition for improving skin elasticity comprising novel ginsenoside

The present specification relates to a composition containing a tea extract with an increased specific ingredient content for prevention or alleviation of lipid metabolism disorders. The use of a preparation method and a composition according to the present specification can effectively prevent and treat lipid metabolism disorders including obesity without side effects, thereby meeting related demands and promoting the development of corresponding industries.

Method for preventing or alleviating lipid metabolism disorders using composition containing green tea extract with increased specific ingredient content

The present invention relates to a compound of Formula 1, and an SIRT 1 activator including, as an active ingredient, derivatives thereof or pharmaceutically acceptable salts thereof. The present invention also relates to a composition including the SIRT 1 activator for detoxification, for the improvement of metabolic disorders, for the prevention or improvement of eye diseases, or the prevention or improvement of immune diseases.

SIRT 1 activator including syringaresinol

The present specification relates to a composition containing novel ginsenoside, (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits excellent effects in glycemic control, lipid metabolic control, cholesterol control, anti-obesity and blood circulation improvement.

Composition comprising novel ginsenoside

The present specification relates to a composition containing novel (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent exercise ability enhancing effect and anti-fatigue effect.

Composition for enhancing exercise ability or anti-fatigue comprising novel ginsenoside

The present invention relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a soybean extract comprising coumestrol as an active ingredient, and more specifically relates to a composition for, inter alia, preventing or treating a climacteric disease, or preventing or improving a climacteric skin symptom comprising a germinated and fermented soybean extract comprising coumestrol as an active ingredient.

Composition for preventing or treating climacteric symptoms comprising soybean extract comprising coumestrol as an active ingredient

The present specification relates to a composition containing novel (20S,24R)-6-O-&#x3b2;-D-glucopyranosyl(1&#x2192;2)-&#x3b2;-D-glucopyranoside-dammar-3-one-20,24-epoxy-6a,12b,25-triol, a pharmaceutically acceptable salt thereof, a hydrate or a solvate thereof as an active ingredient. The composition exhibits an excellent skin brightening effect.

Growing community of inventors

Yongin-si, South Korea

Hyun Woo Jeong